-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: Leronlimab (PRO-140)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-010 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-010 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-010 in Solid Tumor Drug Details: PEP-010 (DPTC-9h) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-07 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-07 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-07 in Mantle Cell Lymphoma Drug Details: PEP-07 (CASC-578) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-07 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-07 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-07 in Refractory Acute Myeloid Leukemia Drug Details: PEP-07 (CASC-578)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-07 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-07 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-07 in Relapsed Acute Myeloid Leukemia Drug Details: PEP-07 (CASC-578)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBX-1416 in Hypoglycemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBX-1416 in Hypoglycemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBX-1416 in Hypoglycemia Drug Details: MBX-1416 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Wound Healing in Wounds
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Wound Healing in Wounds Drug Details: Biologic is under development for the treatment of wound healing....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acute Myocardial Infarction in Myocardial Infarction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acute Myocardial Infarction in Myocardial Infarction Drug Details: Biologic is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBX-2109 in Hypoparathyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBX-2109 in Hypoparathyroidism report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBX-2109 in Hypoparathyroidism Drug Details: MBX-2109 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMP-731 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMP-731 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMP-731 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: GSK-2831781...